• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 16
  3. 17
  4. 18
  5. 19
  6. 20
  7. …
  • Long COVID symptoms may vary with variants

    27 March, 2022

    Long COVID symptoms may be different with different variants.

    COVID-19

  • Pregnant People Face Higher Severe COVID-19 Risks

    27 March, 2022

    Pregnant people who contract the coronavirus are more likely to develop a severe form of the disease, die from COVID-19 and/or deliver prematurely...

    COVID-19

  • Molnupiravir (Lagevrio) approved for COVID-19 treatment

    South Korea // 26 March, 2022

    Lagevrio gets authorisation for COVID-19 treatment

    COVID-19

  • ETAGE updates COVID-19 vaccine recommendations

    25 March, 2022

    Shorter time to booster, and vaccinating adolescents…

    COVID-19

  • Vaccine Update - Fourth dose for elderly

    Finland // 25 March, 2022

    Health authorities are recommending a fourth dose for everyone aged 80 years and above...

    COVID-19

  • COVID-19 Update – Omicron BA.2 accounting for majority of cases

    Myanmar // 23 March, 2022

    Health authorities are monitoring the spread of cases...

    COVID-19

  • Trend of new COVID-19 cases declining

    Malaysia // 23 March, 2022

    Omicron is the dominant variant....

    COVID-19

  • Vaccine Update – Vaccination eligibility age threshold lowered

    Zimbabwe // 22 March, 2022

    Health authorities have announced that children aged 12 years and above are now eligible for vaccination...

    COVID-19

  • First wave of activity

    Cook Islands // 21 March, 2022

    Community transmission is occurring...

    COVID-19

  • New COVID-19 vaccine trial launched to evaluate reduced dose booster shots

    14 March, 2022

    Study into fractionated COVID-19 booster shots announced...

    COVID-19

  • ECDC Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older

    14 March, 2022

    ECDC interim report into COVID-19 vaccine effectiveness against severe infection...

    COVID-19

  • CDC extends mask mandate on public transportation

    United States // 11 March, 2022

    Revised policy to follow…

    COVID-19

  • Delta-Omicron recombinant confirmed

    11 March, 2022

    With cases detected across France, Denmark, Netherlands, UK and US...

    COVID-19

  • Aspen and Johnson & Johnson agree to manufacture and supply Aspenovax throughout Africa

    South Africa // 10 March, 2022

    Aspenovax to be manufactured in Africa...

    COVID-19

  • Record number of new COVID-19 cases

    Vietnam // 10 March, 2022

    Over 265,000 new locally-acquired cases have been recorded....

    COVID-19

  • Vaccine update- Fourth dose to be offered to at-risk groups

    Spain // 10 March, 2022

    Spain will start offering a fourth dose...

    COVID-19

  • Vaccine Update – Novavax approved for 18 years and above and as a booster shot

    Sweden // 10 March, 2022

    The Public Health Agency of Sweden has approved Novavax for 18 years and above...

    COVID-19

  • Pfizer begins Paxlovid trials for individuals aged 6 to 17

    United States // 10 March, 2022

    Pfizer has launched trials for Paxlovid in under 18 years...

    COVID-19

  • Zifivax COVID-19 vaccine conditionally approved

    China // 09 March, 2022

    Manufactured by Anhui Zhifei Longcom Biopharmaceutical

    COVID-19

  • Study: Mild COVID-19 may alter brain structure

    08 March, 2022

    Structural changes in the brain have been observed in COVID-19 recovered patients with...

    COVID-19

  1. …
  2. 16
  3. 17
  4. 18
  5. 19
  6. 20
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS